Davenport & CO LLC Abbott Laboratories Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Davenport & CO LLC holds 935,583 shares of ABT stock, worth $110 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

935,583

Previous 935,179 0.04%

Holding current value

$110 Million

Previous $97.2 Million 9.77%

% of portfolio

0.63%

Previous 0.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $40,428 - $47,724	404 Added 0.04%	935,583 $107 Million
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $3.15 Million - $3.52 Million	-31,274 Reduced 3.24%	935,179 $97.2 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $100,867 - $111,404	921 Added 0.1%	966,453 $110 Million
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $898,743 - $1.1 Million	9,965 Added 1.04%	965,532 $106 Million
Q3 2023 Oct 17, 2023	BUY	$95.53 - $114.62 $15.6 Million - $18.7 Million	162,877 Added 20.55%	955,567 $92.5 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $1.58 Million - $1.76 Million	-15,711 Reduced 1.94%	792,690 $86.4 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $450,883 - $530,716	-4,655 Reduced 0.57%	808,401 $81.9 Million
Q4 2022 Jan 20, 2023	BUY	$95.06 - $111.52 $14.4 Million - $16.9 Million	151,273 Added 22.86%	813,056 $0
Q3 2022 Oct 11, 2022	SELL	$96.76 - $112.03 $1.17 Million - $1.36 Million	-12,096 Reduced 1.79%	661,783 $64.1 Million
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $428,183 - $517,537	-4,195 Reduced 0.62%	673,879 $73.1 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $2.61 Million - $3.18 Million	-22,851 Reduced 3.26%	678,074 $80.3 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $1.42 Million - $1.74 Million	-12,318 Reduced 1.73%	700,925 $98.6 Million
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $9.1 Million - $10.1 Million	78,019 Added 12.28%	713,243 $84.3 Million
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $3.26 Million - $3.84 Million	30,809 Added 5.1%	635,224 $73.6 Million
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $262,304 - $309,034	-2,410 Reduced 0.4%	604,415 $72.4 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $2.05 Million - $2.23 Million	19,519 Added 3.32%	606,825 $66.4 Million
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $190,702 - $231,594	-2,081 Reduced 0.35%	587,306 $63.9 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $602,605 - $771,260	7,870 Added 1.35%	589,387 $53.9 Million
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $29.8 Million - $43.5 Million	473,910 Added 440.41%	581,517 $45.9 Million
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $158,511 - $176,460	2,019 Added 1.91%	107,607 $9.35 Million
Q3 2019 Oct 16, 2019	BUY	$81.84 - $88.74 $78,975 - $85,634	965 Added 0.92%	105,588 $8.88 Million
Q2 2019 Jul 10, 2019	SELL	$72.88 - $85.0 $908,886 - $1.06 Million	-12,471 Reduced 10.65%	104,623 $8.8 Million
Q1 2019 Apr 17, 2019	BUY	$66.22 - $80.06 $47,281 - $57,162	714 Added 0.61%	117,094 $9.36 Million
Q4 2018 Jan 28, 2019	SELL	$65.56 - $74.27 $6,752 - $7,649	-103 Reduced 0.09%	116,380 $8.42 Million
Q3 2018 Oct 11, 2018	SELL	$60.81 - $73.36 $331,171 - $399,518	-5,446 Reduced 4.47%	116,483 $8.55 Million
Q2 2018 Jul 09, 2018	SELL	$57.57 - $63.54 $263,728 - $291,076	-4,581 Reduced 3.62%	121,929 $7.44 Million
Q1 2018 Apr 04, 2018	SELL	$56.27 - $63.62 $43,665 - $49,369	-776 Reduced 0.61%	126,510 $7.58 Billion
Q4 2017 Jan 17, 2018	BUY	$53.68 - $57.47 $421,871 - $451,656	7,859 Added 6.58%	127,286 $7.26 Billion
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $5.74 Million - $6.41 Million	119,427	119,427 $6.37 Billion

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account